UHRF2 and neoplasm: Immunohistochemistry staining for DNMT3A confirmed increased levels of DNMT3A in the tumors derived from the shUHRF2-expressing A549 cells (Figure 6i), indicating that increased DNMT3A levels upon downregulation of UHRF2 are associated with drastically reduced tumor growth.